{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:22:44Z","timestamp":1769091764695,"version":"3.49.0"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"abstract":"<jats:p>Background. The use of opioid therapy for sedation and analgesia among ventilated infants varies among care providers. The impact of opioid therapy early in the neonatal course of respiratory distress syndrome (RDS) on pulmonary outcomes is not known.<\/jats:p>\n               <jats:p>Objective. We tested the hypothesis that preterm neonates randomized to the morphine infusion group would have improved ventilatory outcomes, measured as shorter durations of ventilator or oxygen therapy, fewer air leaks, and lower incidence of bronchopulmonary dysplasia.<\/jats:p>\n               <jats:p>Methods. All 898 subjects (gestational age [GA] of \u226523 to \u226432 weeks) who were enrolled in the Neurologic Outcomes and Preemptive Analgesia in Neonates (NEOPAIN) trial formed the study cohort (morphine: 449 patients; placebo: 449 patients). Subjects received the masked study drug until they were weaned from the ventilator or for 14 days, whichever occurred earlier. Outcome measures included air leaks, duration of ventilation or oxygen therapy, hospitalization, bronchopulmonary dysplasia, and death.<\/jats:p>\n               <jats:p>Results. Subjects in the 2 groups had similar baseline characteristics (mean \u00b1 SD, morphine versus placebo: GA: 27.3 \u00b1 2.3 vs 27.4 \u00b1 2.3 weeks; birth weight: 1037 \u00b1 340 vs 1054 \u00b1 354 g). Infants in the morphine group required ventilator therapy significantly longer, compared with the placebo group (median [interquartile range]: 7 days [4\u201320 days] vs 6 days [3\u201319 days]). This difference in ventilation duration was significant for infants with GA of 27 to 29 weeks (6 days [4\u201312 days] vs 5 days [2\u20139 days]) and 30 to 32 weeks (4 days [3\u20136 days] vs 3 days [2\u20135 days]). Infants who received additional analgesia with intermittent morphine doses in both groups were sicker than those who were not given open-label morphine. After adjustment for birth weight, Clinical Risk Index for Babies scores, maternal chorioamnionitis, RDS requiring surfactant, and patent ductus arteriosus in a logistic regression model, the use of additional analgesia with morphine was associated independently with increased air leaks and longer durations of high-frequency ventilation, nasal continuous positive airway pressure, and oxygen therapy.<\/jats:p>\n               <jats:p>Conclusions. Morphine infusions do not improve short-term pulmonary outcomes among ventilated preterm neonates. Additional morphine doses were associated with worsening respiratory outcomes among preterm neonates with RDS.<\/jats:p>","DOI":"10.1542\/peds.2004-2123","type":"journal-article","created":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T14:55:38Z","timestamp":1122994538000},"page":"352-359","source":"Crossref","is-referenced-by-count":92,"title":["Morphine Administration and Short-term Pulmonary Outcomes Among Ventilated Preterm Infants"],"prefix":"10.1542","volume":"116","author":[{"given":"Vineet","family":"Bhandari","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Albert Einstein Medical Center, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena L.","family":"Bergqvist","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Neonatal Research Unit, Astrid Lindgren's Children's Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari S.","family":"Kronsberg","sequence":"additional","affiliation":[{"name":"Maryland Medical Research Institute, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Barton","sequence":"additional","affiliation":[{"name":"Maryland Medical Research Institute, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwaljeet J. S.","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the NEOPAIN Trial Investigators Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,8,1]]},"reference":[{"key":"2021121003170710500_R1","doi-asserted-by":"crossref","unstructured":"Anand KJS. Clinical importance of pain and stress in preterm neonates. Biol Neonate.\u20081998;73:1\u20139","DOI":"10.1159\/000013953"},{"key":"2021121003170710500_R2","doi-asserted-by":"crossref","unstructured":"Kahn DJ, Richardson DK, Gray JE, et al. Variation among neonatal intensive care units in narcotic administration. Arch Pediatr Adolesc Med.\u20081998;152:844\u2013851","DOI":"10.1001\/archpedi.152.9.844"},{"key":"2021121003170710500_R3","doi-asserted-by":"crossref","unstructured":"Kennedy KA, Tyson JE. Narcotic analgesia for ventilated newborns: are placebo-controlled trials ethical and necessary?J Pediatr.\u20081999;134:127\u2013129","DOI":"10.1016\/S0022-3476(99)70399-9"},{"key":"2021121003170710500_R4","doi-asserted-by":"crossref","unstructured":"Dyke MP, Kohan R, Evans S. Morphine increases synchronous ventilation in preterm infants. J Paediatr Child Health.\u20081995;31:176\u2013179","DOI":"10.1111\/j.1440-1754.1995.tb00780.x"},{"key":"2021121003170710500_R5","doi-asserted-by":"crossref","unstructured":"Anand KJS, McIntosh N, Lagercrantz H, et al. Analgesia and sedation in preterm neonates who require ventilatory support: results from the NOPAIN trial. Arch Pediatr Adolesc Med.\u20081999;153:331\u2013338","DOI":"10.1001\/archpedi.153.4.331"},{"key":"2021121003170710500_R6","doi-asserted-by":"crossref","unstructured":"Orsini AJ, Leef KH, Costarino A, Dettore MD, Stefano JL. Routine use of fentanyl infusions for pain and stress reduction in infants with respiratory distress syndrome. J Pediatr.\u20081996;129:140\u2013145","DOI":"10.1016\/S0022-3476(96)70201-9"},{"key":"2021121003170710500_R7","doi-asserted-by":"crossref","unstructured":"Lago P, Benini F, Agosto C, Zacchello F. Randomised controlled trial of low dose fentanyl infusion in preterm infants with hyaline membrane disease. Arch Dis Child Fetal Neonatal Ed.\u20081998;79:F194\u2013F197","DOI":"10.1136\/fn.79.3.F194"},{"key":"2021121003170710500_R8","doi-asserted-by":"crossref","unstructured":"Anand KJS, Hall RW, Desai NS, et al. Effect of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomized trial. Lancet.\u20082004;263:1673\u20131682","DOI":"10.1016\/S0140-6736(04)16251-X"},{"key":"2021121003170710500_R9","doi-asserted-by":"crossref","unstructured":"Bhat R, Abu-Harb M, Chari G, Gulati A. Morphine metabolism in acutely ill preterm newborn infants. J Pediatr.\u20081992;120:795\u2013799","DOI":"10.1016\/S0022-3476(05)80251-3"},{"key":"2021121003170710500_R10","doi-asserted-by":"crossref","unstructured":"Barrett DA, Barker DP, Rutter N, Pawula M, Shaw PN. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. Br J Clin Pharmacol.\u20081996;41:531\u2013537","DOI":"10.1046\/j.1365-2125.1996.03539.x"},{"key":"2021121003170710500_R11","doi-asserted-by":"crossref","unstructured":"Barrett DA, Elias-Jones AC, Rutter N, Shaw PN, Davis SS. Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol.\u20081991;32:31\u201337","DOI":"10.1111\/j.1365-2125.1991.tb05609.x"},{"key":"2021121003170710500_R12","doi-asserted-by":"crossref","unstructured":"Hartley R, Green M, Quinn M, Levene MI. Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child.\u20081993;69:55\u201358","DOI":"10.1136\/adc.69.1_Spec_No.55"},{"key":"2021121003170710500_R13","doi-asserted-by":"crossref","unstructured":"Bhat R, Chari G, Gulati A, Aldana O, Velamati R, Bhargava H. Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. J Pediatr.\u20081990;117:477\u2013481","DOI":"10.1016\/S0022-3476(05)81102-3"},{"key":"2021121003170710500_R14","doi-asserted-by":"crossref","unstructured":"Scott CS, Riggs KW, Ling EW, et al. Morphine pharmacokinetics and pain assessment in premature newborns. J Pediatr.\u20081999;135:423\u2013429","DOI":"10.1016\/S0022-3476(99)70163-0"},{"key":"2021121003170710500_R15","doi-asserted-by":"crossref","unstructured":"Zahorodny W, Rom C, Whitney W, et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr.\u20081998;19:89\u201393","DOI":"10.1097\/00004703-199804000-00005"},{"key":"2021121003170710500_R16","doi-asserted-by":"crossref","unstructured":"Cunningham N. Inclusion of the nonverbal patient: a matter of moral emergency. Pain Forum.\u20081999;8:110\u2013111","DOI":"10.1016\/S1082-3174(99)70052-8"},{"key":"2021121003170710500_R17","doi-asserted-by":"crossref","unstructured":"International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet.\u20081993;342:193\u2013198","DOI":"10.1016\/0140-6736(93)92296-6"},{"key":"2021121003170710500_R18","doi-asserted-by":"crossref","unstructured":"Wood CM, Rushforth JA, Hartley R, Dean H, Wild J, Levene MI. Randomized double blind trial of morphine versus diamorphine for sedation of preterm infants. Arch Dis Child Fetal Neonatal Ed.\u20081998;79:F34\u2013F39","DOI":"10.1136\/fn.79.1.F34"},{"key":"2021121003170710500_R19","doi-asserted-by":"crossref","unstructured":"Jacqz-Aigrain E, Daoud P, Burtin P, Desplanques L, Beaufils F. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet.\u20081994;344:646\u2013650","DOI":"10.1016\/S0140-6736(94)92085-0"},{"key":"2021121003170710500_R20","unstructured":"Bhandari V, Narang A. Role of morphine or triclofos in neonatal ventilation: a pilot study [abstract]. Bull Natl Neonatol Forum.\u20081992;6:8\u20139"},{"key":"2021121003170710500_R21","doi-asserted-by":"crossref","unstructured":"Bhandari A, Bhandari V. Pathogenesis, pathology, and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature neonates. Front Biosci.\u20082003;8:e370\u2013e380","DOI":"10.2741\/1060"},{"key":"2021121003170710500_R22","doi-asserted-by":"crossref","unstructured":"Miller J, Law AB, Parker RA, Sundell H, Silberberg AR, Cotton RB. Effects of morphine and pancuronium on lung volume and oxygenation in premature infants with hyaline membrane disease. J Pediatr.\u20081994;125:97\u2013103","DOI":"10.1016\/S0022-3476(94)70133-4"},{"key":"2021121003170710500_R23","doi-asserted-by":"crossref","unstructured":"Alexander SM, Todres ID. The use of sedation and muscle relaxation in the ventilated infant. Clin Perinatol.\u20081998;25:63\u201378","DOI":"10.1016\/S0095-5108(18)30136-2"},{"key":"2021121003170710500_R24","unstructured":"Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for the sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev.\u20082000;(2): CD002052"},{"key":"2021121003170710500_R25","doi-asserted-by":"crossref","unstructured":"Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA.\u20082003;290:2419\u20132427","DOI":"10.1001\/jama.290.18.2419"},{"key":"2021121003170710500_R26","doi-asserted-by":"crossref","unstructured":"Quinn MW, Vokes A. Effect of morphine on respiratory drive in trigger ventilated pre-term infants. Early Hum Dev.\u20082000;59:27\u201335","DOI":"10.1016\/S0378-3782(00)00082-7"},{"key":"2021121003170710500_R27","doi-asserted-by":"crossref","unstructured":"Corrupt PA, Testa A, Bechalany A, El Tayar N, Descas P, Perrisoud D. Metabolites of morphine as molecular chameleons. J Med Chem.\u20081991;34:1272\u20131275","DOI":"10.1021\/jm00108a005"},{"key":"2021121003170710500_R28","doi-asserted-by":"crossref","unstructured":"Christrup LL. Morphine metabolites. Acta Anaesth Scand.\u20081997;41:116\u2013122","DOI":"10.1111\/j.1399-6576.1997.tb04625.x"},{"key":"2021121003170710500_R29","doi-asserted-by":"crossref","unstructured":"Osborne RJ, Joel SP, Trew D, Slevin M. Analgesic activity of morphine-6-glucuronide. Lancet.\u20081988;1:828","DOI":"10.1016\/S0140-6736(88)91691-1"},{"key":"2021121003170710500_R30","doi-asserted-by":"crossref","unstructured":"Inturrisi CE. Morphine-6-glucuronide: a potent \u03bc-agonist. Life Sci.\u20081987;41:2845\u20132849","DOI":"10.1016\/0024-3205(87)90431-0"},{"key":"2021121003170710500_R31","doi-asserted-by":"crossref","unstructured":"Suzuki N, Kalso E, Rosenberg PH. Intrathecal morphine-3-glucuronide does not antagonise spinal anti-nociception by morphine or morphine-6-glucuronide in rats. Eur J Pharmacol.\u20081993;249:247\u2013250","DOI":"10.1016\/0014-2999(93)90441-J"},{"key":"2021121003170710500_R32","doi-asserted-by":"crossref","unstructured":"Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide: a potent antagonist of morphine analgesia. Life Sci.\u20081990;47:579","DOI":"10.1016\/0024-3205(90)90619-3"},{"key":"2021121003170710500_R33","doi-asserted-by":"crossref","unstructured":"Bouwmeester NJ, van den Anker JN, Hop WC, Anand KJ, Tibboel D. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth.\u20082003;90:642\u2013652","DOI":"10.1093\/bja\/aeg121"},{"key":"2021121003170710500_R34","doi-asserted-by":"crossref","unstructured":"Bouwmeester NJ, Hop WC, van Dijk M, Anand KJ, van den Anker JN, Tibboel D. Postoperative pain in the neonate: age-related differences in morphine requirements and metabolism. Intensive Care Med.\u20082003;29:2009\u20132015","DOI":"10.1007\/s00134-003-1899-4"},{"key":"2021121003170710500_R35","doi-asserted-by":"crossref","unstructured":"Kaaresen PI, Du\u0300hlen G, Fundingsrud HP, Dahl LB. The use of CRIB (Clinical Risk Index for Babies) score in auditing the performance of one neonatal intensive care unit. Acta Paediatr.\u20081998;87:195\u2013200","DOI":"10.1111\/j.1651-2227.1998.tb00975.x"},{"key":"2021121003170710500_R36","doi-asserted-by":"crossref","unstructured":"Rautonen J, Ma\u0308kela\u0308 A, Boyd H, Apajasalo M, Pohjavuori M. CRIB and SNAP: assessing the risk of death for preterm infants. Lancet.\u20081994;343:1272\u20131273","DOI":"10.1016\/S0140-6736(94)92158-X"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/2\/352\/1004361\/zpe00805000352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/2\/352\/1004361\/zpe00805000352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T09:49:41Z","timestamp":1639129781000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/2\/352\/62873\/Morphine-Administration-and-Short-term-Pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,8,1]]},"published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2123","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,1]]}}}